News Announcement

Fresenius Kabi Oncology: Delisting Update

With reference to the earlier announcement dated October 12, 2013 regarding Delisting Updates. Fresenius Kabi Oncology Ltd has now informed BSE that Securities and Exchange Board of India (SEBI), vide its letter dated October 14, 2013, has advised the Company to approach Securities Appellate Tribunal (SAT) for seeking any relief including extension of time.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.


These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan